JSAM
IMCR icon

J. Safra Asset Management’s Immunocore IMCR Stock Holding History

J. Safra Asset Management’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.97K Sell
188
-39
-17% -$1.15K ﹤0.01% 467
2026
Q1 		$6.84K Buy
227
+152
+203% +$4.92K ﹤0.01% 416
2025
Q4 		$2.6K Hold
75
– – ﹤0.01% 517
2025
Q3 		$2.73K Hold
75
– – ﹤0.01% 363
2025
Q2 		$2.35K Buy
+75
New +$2.33K ﹤0.01% 346
2025
Q1 		– Sell
-5
Closed -$145 – 367
2024
Q4 		$145 Hold
5
– – ﹤0.01% 339
2024
Q3 		$157 Buy
+5
New +$182 ﹤0.01% 298

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

J. Safra Asset Management's IMCR Position: Q2 2026 in Review

J. Safra Asset Management reduced its Immunocore (IMCR) stake by 17% in Q2 2026, selling an estimated $1.15K and leaving 188 shares worth $5.97K. The position accounts for ﹤0.01% of the portfolio, ranked #467.

J. Safra Asset Management first reported a position in IMCR in Q3 2024 and has held it in 7 quarters since. The position peaked at $6.84K in Q1 2026. 135 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • J. Safra Asset Management held 188 shares of Immunocore worth $5.97K as of Q2 2026.
  • J. Safra Asset Management sold 39 Immunocore shares in Q2 2026, an estimated $1.15K.
  • Immunocore made up ﹤0.01% of J. Safra Asset Management's portfolio in Q2 2026, its #467 holding.
  • J. Safra Asset Management first reported a position in Immunocore in Q3 2024 and has held it in 7 quarters since.
  • J. Safra Asset Management's Immunocore position peaked at $6.84K in Q1 2026.
  • 135 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on J. Safra Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.